Mr. Kight created the “Source Rule”, which is widely credited as a primary legal foundation for the contemporary hemp market in cannabinoids and other cannabis materials.
Live Video-Broadcast: January 31, 2025
Select Your State Below to View CLE Credit Information
Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs
This CLE program offers a comprehensive examination of the current state and federal regulations governing hemp derived cannabinoids, such as Delta-8 THC, THCO, CBD, and other cannabinoids. Attorneys will gain valuable insights into advising clients on compliance with evolving hemp/cannabis laws, implementing effective risk mitigation strategies, the science of hemp as it relates to the legal status of the products, testing protocols and legal issues, companies that participate in both the marijuana and hemp sectors of the cannabis market, and addressing licensing requirements.
The course will explore the legal risks tied to the marketing and sale of cannabinoid products, as well as potential regulatory changes that could impact on the industry. Additionally, participants will learn how to prepare clients for future legal shifts in cannabis regulation to ensure long-term compliance and success.
This course is co-sponsored with myLawCLE.
Key topics to be discussed:
Date / Time: January 31, 2025
Closed-captioning available
Rod Kight | Kight Law Office, PC
Rod Kight is a cannabis business law attorney. He created the “Source Rule”, which is widely credited as a primary legal foundation for the contemporary hemp market in cannabinoids and other cannabis materials. Based in North Carolina and Mexico, Rod represents legal cannabis businesses throughout the world, is editor and chief writer of the Kight On Cannabis law blog (www.kightoncannabis.com), and is the author of “Cannabis Business Law-What You Need to Know”, published by Aspatore Books. Rod has served on the advisory board for the American Journal of Endocannabinoid Medicine (AJEM), for which he wrote a legal column. He also served on the board of directors for an international can-nabis and psychedelics company.
Rod is frequently quoted on cannabis matters by trade publications and major media outlets including the Wall Street Journal, NPR, Time, Washington Post, Forbes, Politico, Salon.com, and Business Insider.
Additionally, Rod has been listed in MG Magazine’s list of “30 Powerful Litigators”, Hemp Connoisseur Magazine’s list of “100 People You Should Know”, and High Time’s “2020 Leaders in Cannabis Law.” He has been part of the legal teams in several high-profile cases against the DEA and various states regarding hemp, has drafted and presented cannabis legislation to a foreign head of state, testified to the FDA about CBD and cannabis compounds, has served as an expert witness in cases in-volving hemp, and co-founded a Mexican import-export company focused on legal cross-border hemp transactions. Rod routinely advises in-house counsel and C-suite level executives on cannabis matters and has discussed cannabis legal issues in numerous conferences and seminars to lawyers, business executives, and public officials. Rod is regularly asked to be a guest speaker on US and international pod-casts about cannabis and psychedelics.
Rod is a strong believer in cannabis for personal and medical use after using it successfully during chemotherapy treatments for cancer (he is in remission). He has been an attorney advocate for NORML and has also been a member of the International Cannabis Bar Association, the National Cannabis Industry Association, the Hemp Industries Association, the Southeast Hemp Association, and the US Hemp Authority.
Rod resides in Mexico and North Carolina with his elementary school sweetheart, Ashley, who is also his office manager. Together they have a blended family with 5 kids. Rod is also an avid musician, hiker, and reader. He can be reached via email ([email protected]) or phone (828-255 9881).
I. Analysis of current state and federal regulations governing Delta-8 THC, THCA, THCO, CBD, and other cannabinoids | 1:00pm – 1:10pm
II. Advising clients on compliance with cannabis laws | 1:10pm – 1:20pm
III. Risk mitigation strategies for clients involved in the production, sale, or distribution of Delta-8 THC and CBD products | 1:20pm – 1:30pm
IV. Scientific issues of importance to attorneys | 1:30pm – 1:40pm
V. Laboratory testing issues | 1:40pm – 2:00pm
Break | 2:00pm – 2:10pm
VI. Licensing requirements and compliance enforcement | 2:10pm –2:30pm
VII. Discussion on the potential changes in cannabis regulation | 2:30pm – 2:40pm
VIII. Preparing clients for future legal shifts in the cannabis industry | 2:40pm – 2:50pm
IX. Legal risks associated with the marketing and sale of cannabinoid products | 2:50pm – 3:10pm